MAX Chat
Company Analysis CellSource Co., Ltd.
1. Summary
Advantages
- The company's current efficiency (ROE=3.89%) is higher than the sector average (ROE=1.54%)
Disadvantages
- Price (687 Β₯) is higher than fair price (133.14 Β₯)
- Dividends (0.4209%) are below the sector average (1.76%).
- The stock's return over the last year (-41.1%) is lower than the sector average (0%).
- Current debt level 1.09% has increased over 5 years from 0.3967%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| CellSource Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -1.7% | 0% | 0.4% |
| 90 days | -8% | 0% | 14.3% |
| 1 year | -41.1% | 0% | 12.7% |
4880 vs Sector: CellSource Co., Ltd. has significantly underperformed the "Healthcare" sector by -41.1% over the past year.
4880 vs Market: CellSource Co., Ltd. has significantly underperformed the market by -53.78% over the past year.
Stable price: 4880 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 4880 with weekly volatility of -0.7904% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (687 Β₯) is higher than the fair price (133.14 Β₯).
Price is higher than fair: The current price (687 Β₯) is 80.6% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (99.37) is higher than that of the sector as a whole (72.5).
P/E vs Market: The company's P/E (99.37) is lower than that of the market as a whole (145.33).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.92) is lower than that of the sector as a whole (69.35).
P/BV vs Market: The company's P/BV (3.92) is lower than that of the market as a whole (148.5).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (5.43) is lower than that of the sector as a whole (89.6).
P/S vs Market: The company's P/S indicator (5.43) is lower than that of the market as a whole (149.54).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (43.16) is higher than that of the sector as a whole (28.83).
EV/Ebitda vs Market: The company's EV/Ebitda (43.16) is lower than that of the market as a whole (147.75).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -2.64% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-2.64%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.45%).
5.4. ROE
ROE vs Sector: The company's ROE (3.89%) is higher than that of the sector as a whole (1.54%).
ROE vs Market: The company's ROE (3.89%) is lower than that of the market as a whole (9.43%).
5.5. ROA
ROA vs Sector: The company's ROA (3.41%) is higher than that of the sector as a whole (0.9718%).
ROA vs Market: The company's ROA (3.41%) is lower than that of the market as a whole (4.67%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (8.38%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.4209% is below the average for the sector '1.76%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.4209% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 0.4209% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (165.42%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
